Enhancing Lysosomal Function as a Therapeutic Strategy for Parkinson’s Disease
Time: 2:00 pm
Details:
- Investigating lysosomal dysfunction in neurodegenerative diseases andwhat this means from a drug development perspective
- Exploring activating TRPML1 as potential treatment for GBA-PD
- Looking through the crystal ball: Outlining future directions
